| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $463.9M | +67.6% |
| Cost of Revenue | $254.4M | +101.5% |
| Gross Profit | $209.5M | +39.1% |
| R&D Expense | $4.0M | -57.9% |
| SG&A Expense | $172.2M | +44.7% |
| Operating Income | $33.3M | +89.0% |
| Interest Expense | $63.2M | +200.8% |
| Pre-tax Income | -$28.8M | -755.0% |
| Income Tax | -$3.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $173.7M | -6.8% |
| Accounts Receivable | $183.1M | +73.0% |
| Inventory | $46.5M | +167.3% |
| Current Assets | $420.0M | +33.1% |
| Total Assets | $1.17B | +69.7% |
| Current Liabilities | $433.7M | +55.1% |
| Total Liabilities | $979.3M | +100.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $124.2M | +20.0% |
| Capital Expenditures | $1.6M | -16.6% |
| Investing Cash Flow | -$573.7M | — |
| Financing Cash Flow | $436.7M | +589.0% |
| Free Cash Flow | $122.6M | +20.7% |
| +94.9% |
| Net Income | -$25.0M | -135.0% |
| EPS (Basic) | -$0.74 | -136.1% |
| EPS (Diluted) | -$0.74 | -139.8% |
| Stockholders' Equity |
| $194.8M |
| -4.0% |